Ocular surface analysis in patients affected with rheumatic diseases;Analisi della superficie oculare in pazienti affetti da malattie reumatiche

Reumatismo

Volumn 56, Issue 4, 2004, Pages 262-271

  Versura, Piera ^a,b   Frigato, M ^a   Bernabini, B ^a   Mule R ^a   Malavolta, N ^a   Campos, E C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dry eye; Rheumatoid arthritis; Schirmer test; Sj gren's sindrome; Tear clearance

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BREAK UP TIME TEST; CLINICAL FEATURE; COMPUTER PROGRAM; CORNEA AESTHESIOMETRY; CORNEA SENSIBILITY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DRY EYE; EYE DISEASE; EYE SURFACE ANALYSIS; FEMALE; FERNING TEST; FUNCTION TEST; HUMAN; JONES TEST; LACRIMAL GLAND FUNCTION; MAJOR CLINICAL STUDY; MALE; OPHTHALMOLOGY; QUESTIONNAIRE; RANK SUM TEST; RHEUMATIC DISEASE; SCHIRMER TEST; SJOEGREN SYNDROME; TEAR CLEARANCE TEST; VITAL STAIN;

ARTHRITIS, RHEUMATOID; CONNECTIVE TISSUE DISEASES; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SURFACE PROPERTIES; TEARS;

EID: 12444288464     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. O'Day DM, Horn JD. The Eye and Rheumatic Disease. In: Kelley WN editor. Textbook of rheumatology, 6th ed. Philadelphia: Saunders, 2001: chapter 29.
2. Tseng SC, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol 1997; 124:825-35.
3. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21: 221-32.
4. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
5. Schiffman RM, Dale Christianson M, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index (OSDI). Arch Ophthalmol 2000; 118: 615-21.
6. Tanenbaum M, McCord CD jr. The lachrymal drainage system. In: Tasman & Jaeger editors. DuanÈs Ophthalmology. Lippincott-Raven Pu, 1998.
7. Ravazzoni L, Ghini C, Macri A, Rolando M. Forecasting of hydrophilic contact lens tolerance by means of tear ferning test. GraefÈs Arch Clin exp Ophthalmol 1998; 236: 354-8.
8. Norn MS. Lissamine green, vital staining of cornea and conjunctiva. Acta Ophthalmol 1973; 51: 483-91.
9. van Bjisterveld OP. Diagnostic test in the sicca syndrome. Arch Ophthalmol 1969; 82: 10-4.
10. Rosenberg ME, Tervo TM, Immonen IJ, Muller IJ, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 2000; 41: 2915-21.
11. De Paiva CS, Plugfelder SC. Tear Clearance Implication for ocular surface health. Exp Eye Res 2004; 78: 395-397.
12. Xu KE, Yagi Y, Toda I, Tsubota K. Tear Function Index. A new measure of dry eye. Arch Ophthalmol 1995; 113: 84-8.
13. Versura P, Profazio V, Cellini M, Torreggiani A, Caramazza R. Eye Discomfort and air pollution. Ophthalmologica 1999; 213: 103-9.
14. Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985; 728-33.
15. Prause JU. Clinical ophthalmological tests for the diagnosis of keratoconjunctivitis sicca. Clin Exp Rheumatol 1989; 7:141-4.
16. Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of Dry Eye Syndrome. Cornea 1994; 13:202-9.
17. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea, 2004; 23: 272-285.
18. Kovacs L, Torok T, Bari F, Keri Z, Kovacs A, Makula E, et al. Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome. Ann Rheum Dis 2000; 59:48-53.
19. Kovacs L, Papos M, Takacs R, Roka R, Csenke Z, Kovacs A, et al. Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjögren's syndrome. Clin Exp Rheumatol 2003; 21:697-703.
20. Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. Scand J Rheumatol 2000; 29:341-8.
21. Bacman S, Sterin-borda L, Camusso JJ. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996; 104:454-9.
22. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren's syndrome. Invest Ophthalmol Vis Sci 2001; 42:321-7.
23. Rolando M. Sjögren's syndrome as seen by an ophthalmologist. Scand J Rheumatol Suppl. 2001; 27-31
24. Chodosh J, Dix R, Howell RC, Stroop WG, Tseng SC. Staining characteristics and antiviral activity of sulphorodamine B and lissamine green B. Invest phthalmol Vis Sci 1994; 351046-58.
25. Rivas L, Murube J, Shalaby O, Oroza MA, Sanz AI. Impression cytology contribution to differential diagnosis of Sjögren syndrome in the ophthalmological clinic. Arch Soc Esp Oftalmol 2002; 77:63-72.